Exenatide

■ Approved product exists

An FDA-approved exenatide product exists. The register holds 2 recorded programs, 0 with a comparable monthly price, across 2 categories of exenatide. Classification recorded October 2026. FDA source.

Byetta (exenatide) is indicated for adults with type 2 diabetes. An approved exenatide product does not establish weight-loss approval or which product, form or indication a provider offers. Indication source.

• Brand exenatide1 entry
• Generic exenatide1 entry

A compounded preparation is not itself an FDA-approved product, so each form is recorded and priced separately rather than rolled together.